Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiu-wei-zhen-xiao is a granule formulation derived from nine different kinds of traditional Chinese medicine. It is being investigated for the treatment of advanced, unresectable hepatocellular carcinoma (HCC). A pilot single-arm clinical trial has been completed to assess its therapeutic efficacy, with primary endpoints focusing on overall survival and secondary endpoints including progression-free survival, quality of life, liver function, coagulation function, tumor size, traditional Chinese medicine syndrome improvement, pain reduction, and toxicity profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiu-wei-zhen-xiao.